A stronger drug than oral Wigovi has been released... Global competition is intensifying
The global obesity drug market is rapidly shifting from injectable treatments to oral medications, marking a possible disruption to the dominance of Novo Nordisk and Eli Lilly.
New smoking cessation medication: an oral solution that will be funded by Health
Since January 1st, the Ministry of Health funds a new smoking cessation medication, Recigarum Oral Solution, which expands options for patients who have difficulty swallowing pills.
With the Wise One: When Gene Therapy Becomes a Hope for Life
The program highlights groundbreaking medical advancements in treating chronic and rare diseases, including FDA approval of a new daily oral medication for weight loss and a gene therapy for spinal muscular atrophy.
Obesity drug ignites competition in America
Novo Nordisk has launched its oral weight loss drug 'Wegovy' in the US, leading to intensified competition in the obesity medication market.